Alhalabi OT, Göttmann M, Gold MP, Schlue S, Hielscher T, Iskar M, Kessler T, Hai L, Lokumcu T, Cousins CC, Herold-Mende C, Heßling B, Horschitz S, Jabali A, Koch P, Baumgärtner U, Day BW, Wick W, Sahm F, Krieg SM, Fraenkel E, Phillips E, Goidts V. Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma. Cancer Lett. 2024 605:217265.
Barton S, Zovko A, Müller C, Krabichler Q, Schulze J, Wagner S, Grinevich V, Shamay-Tsoory S, Hurlemann R. A translational neuroscience perspective on loneliness: Narrative review focusing on social interaction, illness and oxytocin. Neurosci Biobehav Rev. 2024 163:105734. Epub 2024 May 23.
Brenner D, Sieverding K, Srinidhi J, Zellner S, Secker C, Yilmaz R, Dyckow J, Amr S, Ponomarenko A, Tunaboylu E, Douahem Y, Schlag JS, Rodríguez Martínez L, Kislinger G, Niemann C, Nalbach K, Ruf WP, Uhl J, Hollenbeck J, Schirmer L, Catanese A, Lobsiger CS, Danzer KM, Yilmazer-Hanke D, Münch C, Koch P, Freischmidt A, Fetting M, Behrends C, Parlato R, Weishaupt JH. A TBK1 variant causes autophagolysosomal and motoneuron pathology without neuroinflammation in mice. J Exp Med. 2024 221(5)
Fazio L, Naik VN, Therpurakal RN, Gomez Osorio FM, Rychlik N, Ladewig J, Strüber M, Cerina M, Meuth SG, Budde T. Retigabine, a potassium channel opener, restores thalamocortical neuron functionality in a murine model of autoimmune encephalomyelitis. Brain Behav Immun. 2024 122:202-215.
Foo JC, Völker MP, Streit F, Frank J, Zacharias N, Zillich L, Sirignano L, Nürnberg P, Wienker TF, Wagner M, Nöthen MM, Nothnagel M, Walter H, Lenz B, Spanagel R, Kiefer F, Winterer G, Rietschel M, Witt SH. Polygenic risk scores for nicotine use and family history of smoking are associated with smoking behaviour. Drug Alcohol Depend. 2024 263:112415. Epub 2024 Aug 15.
Hai L, Hoffmann DC, Wagener RJ, Azoŕin DD, Hausmann D, Xie R, Huppertz MC, Hiblot J, Sievers P, Heuer S, Ito J, Cebulla G, Kourtesakis A, Kaulen LD, Ratliff M, Mandelbaum H, Jung E, Jabali A, Horschitz S, Ernst KJ, Reibold D, Warnken U, Venkataramani V, Will R, Suvà ML, Herold-Mende C, Sahm F, Winkler F, Schlesner M, Wick W, Kessler T. A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1. Nat Commun. 2024 15(1):968.
Haubenreich C, Lenz M, Schuppert A, Peitz M, Koch P, Zenke M, Brüstle O. Epigenetic and Transcriptional Shifts in Human Neural Stem Cells after Reprogramming into Induced Pluripotent Stem Cells and Subsequent Redifferentiation. Int J Mol Sci. 2024 25(6)
Schlieper-Scherf S, Hebach N, Hausmann D, Azoŕin DD, Hoffmann DC, Horschitz S, Maier E, Koch P, Karreman MA, Etminan N, Ratliff M. Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models. J Neurooncol. 2024 170(1):139-151.
Zaidi D, Chinnappa K, Yigit BN, Viola V, Cifuentes-Diaz C, Jabali A, Uzquiano A, Lemesre E, Perez F, Ladewig J, Ferent J, Ozlu N, Francis F. Forebrain Eml1 depletion reveals early centrosomal dysfunction causing subcortical heterotopia. J Cell Biol. 2024 223(12)